Cosmo Pharmaceuticals N.V. (SWX: COPN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
79.10
-0.40 (-0.50%)
Sep 4, 2024, 2:11 PM CET
79.77%
Market Cap 1.28B
Revenue 178.46M
Net Income 66.99M
Shares Out 16.05M
EPS 4.16
PE Ratio 19.12
Forward PE 11.62
Dividend 1.88 (2.36%)
Ex-Dividend Date Jul 10, 2024
Volume 6,855
Open 78.30
Previous Close 79.50
Day's Range 78.30 - 79.60
52-Week Range 33.70 - 80.60
Beta 1.25
Analysts n/a
Price Target n/a
Earnings Date Oct 24, 2024

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Sector Healthcare
Founded 1997
Employees 339
Stock Exchange SIX Swiss Exchange
Ticker Symbol COPN
Full Company Profile

News

There is no news available yet.